The ICR describes the information
collection involved with the De Novo classification process for
medical devices. FDA uses the information in the De Novo request to
evaluate whether the medical device may be reclassified from Class
III to Class I or II, and if applicable, to determine the general
and/or special controls necessary to sufficiently regulate the
medical device. Respondents to the information collection are
medical device manufacturers.
Our estimated burden for the
information collection reflects an overall increase of 3,400 hours.
We attribute this adjustment to the addition of the Acceptance
Checklist and the Recommended Content Checklist and to an increase
in the number of submissions we received during the approval
period.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.